We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Frankfurt Thrombophilia Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00683397
Recruitment Status : Completed
First Posted : May 23, 2008
Last Update Posted : April 19, 2017
Information provided by (Responsible Party):

Study Description
Brief Summary:
Consecutive patients with acute or previous venous thromboembolism are enrolled in this registry. Using a standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening for thrombophilic disorders were additionally entered into the database.

Condition or disease Intervention/treatment
Venous Thromboembolism Other: Blood sampling

Study Design

Study Type : Observational
Actual Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Frankfurt Thrombophilia Registry - Evaluation of Patients With Venous Thromboembolism
Study Start Date : May 2008
Primary Completion Date : December 2014
Study Completion Date : December 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
Patients with acute or previous venous thromboembolism >18 years of age
Other: Blood sampling
Screening of thrombophilia

Outcome Measures

Biospecimen Retention:   Samples With DNA
whole blood, serum

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
consecutive patients with acute or previous VTE >18 years of age

Inclusion Criteria:

  • Acute or previous VTE

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00683397

Cardioangiologisches Centrum Bethanien
Frankfurt/Main, Hessen, Germany, 60389
Sponsors and Collaborators
Cardioangiologisches Centrum Bethanien
Principal Investigator: Edelgard Lindhoff-Last, Professor Cardioangiologisches Zentrum Bethanien
More Information


Responsible Party: Prof. Dr. med. E. Lindhoff-Last, M.D., Cardioangiologisches Centrum Bethanien
ClinicalTrials.gov Identifier: NCT00683397     History of Changes
Other Study ID Numbers: MAISTHRO Study 93/08
First Posted: May 23, 2008    Key Record Dates
Last Update Posted: April 19, 2017
Last Verified: April 2017

Keywords provided by Prof. Dr. med. E. Lindhoff-Last, Cardioangiologisches Centrum Bethanien:
risk factors

Additional relevant MeSH terms:
Venous Thromboembolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Hematologic Diseases